Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.

MLA

Ali, Zahid, et al. “Long-Term Clinical Efficacy and Safety of Thalidomide in Patients with Transfusion-Dependent β-Thalassemia: Results from Thal-Thalido Study.” Scientific Reports, vol. 13, no. 1, Aug. 2023, p. 13592. EBSCOhost, https://doi.org/10.1038/s41598-023-40849-4.

APA

Ali, Z., Ismail, M., Rehman, I. U., Rani, G. F., Ali, M., & Khan, M. T. M. (2023). Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study. Scientific Reports, 13(1), 13592. https://doi.org/10.1038/s41598-023-40849-4

Chicago

Ali, Zahid, Mohammad Ismail, Inayat Ur Rehman, Gulab Fatima Rani, Muhammad Ali, and Muhammad Tariq Masood Khan. 2023. “Long-Term Clinical Efficacy and Safety of Thalidomide in Patients with Transfusion-Dependent β-Thalassemia: Results from Thal-Thalido Study.” Scientific Reports 13 (1): 13592. doi:10.1038/s41598-023-40849-4.